Targeting SOD1 reduces experimental non-small-cell lung cancer

被引:163
作者
Glasauer, Andrea [1 ]
Sena, Laura A. [1 ]
Diebold, Lauren P. [1 ]
Mazar, Andrew P. [2 ,3 ]
Chandel, Navdeep S. [1 ]
机构
[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA
关键词
SUPEROXIDE-DISMUTASE-1; SOD1; COPPER-BINDING; INACTIVATION; GLUTATHIONE; ACTIVATION; ATN-224; DEATH; NRF2; MITOCHONDRIA; ANTIOXIDANT;
D O I
10.1172/JCI71714
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Approximately 85% of lung cancers are non-small-cell lung cancers (NSCLCs), which are often diagnosed at an advanced stage and associated with poor prognosis. Currently, there are very few therapies available for NSCLCs due to the recalcitrant nature of this cancer. Mutations that activate the small GTPase KRAS are found in 20% to 30% of NSCLCs. Here, we report that inhibition of superoxide dismutase 1 (SOD1) by the small molecule ATN-224 induced cell death in various NSCLC cells, including those harboring KRAS mutations. ATN-224-dependent SOD1 inhibition increased superoxide, which diminished enzyme activity of the antioxidant glutathione peroxidase, leading to an increase in intracellular hydrogen peroxide (H2O2) levels. We found that ATN-224-induced cell death was mediated through H2O2-dependent activation of P38 MAPK and that P38 activation led to a decrease in the antiapoptotic factor MCL1, which is often upregulated in NSCLC. Treatment with both ATN-224 and ABT-263, an inhibitor of the apoptosis regulators BCL2/BCLXL, augmented cell death. Furthermore, we demonstrate that ATN-224 reduced tumor burden in a mouse model of NSCLC. Our results indicate that antioxidant inhibition by ATN-224 has potential clinical applications as a single agent, or in combination with other drugs, for the treatment of patients with various forms of NSCLC, including KRAS-driven cancers.
引用
收藏
页码:117 / 128
页数:12
相关论文
共 42 条
  • [1] Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents
    Antonarakis, Emmanuel S.
    Zahurak, Marianna L.
    Lin, Jianqing
    Keizman, Daniel
    Carducci, Michael A.
    Eisenberger, Mario A.
    [J]. CANCER, 2012, 118 (06) : 1533 - 1542
  • [2] Berenson J.R., 2006, Blood, V108, P2593
  • [3] The landscape of somatic copy-number alteration across human cancers
    Beroukhim, Rameen
    Mermel, Craig H.
    Porter, Dale
    Wei, Guo
    Raychaudhuri, Soumya
    Donovan, Jerry
    Barretina, Jordi
    Boehm, Jesse S.
    Dobson, Jennifer
    Urashima, Mitsuyoshi
    Mc Henry, Kevin T.
    Pinchback, Reid M.
    Ligon, Azra H.
    Cho, Yoon-Jae
    Haery, Leila
    Greulich, Heidi
    Reich, Michael
    Winckler, Wendy
    Lawrence, Michael S.
    Weir, Barbara A.
    Tanaka, Kumiko E.
    Chiang, Derek Y.
    Bass, Adam J.
    Loo, Alice
    Hoffman, Carter
    Prensner, John
    Liefeld, Ted
    Gao, Qing
    Yecies, Derek
    Signoretti, Sabina
    Maher, Elizabeth
    Kaye, Frederic J.
    Sasaki, Hidefumi
    Tepper, Joel E.
    Fletcher, Jonathan A.
    Tabernero, Josep
    Baselga, Jose
    Tsao, Ming-Sound
    Demichelis, Francesca
    Rubin, Mark A.
    Janne, Pasi A.
    Daly, Mark J.
    Nucera, Carmelo
    Levine, Ross L.
    Ebert, Benjamin L.
    Gabriel, Stacey
    Rustgi, Anil K.
    Antonescu, Cristina R.
    Ladanyi, Marc
    Letai, Anthony
    [J]. NATURE, 2010, 463 (7283) : 899 - 905
  • [4] INACTIVATION OF GLUTATHIONE-PEROXIDASE BY SUPEROXIDE RADICAL
    BLUM, J
    FRIDOVICH, I
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 240 (02) : 500 - 508
  • [5] Regulation of cancer cell metabolism
    Cairns, Rob A.
    Harris, Isaac S.
    Mak, Tak W.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (02) : 85 - 95
  • [6] Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation
    Chen, Shuang
    Dai, Yun
    Harada, Hisashi
    Dent, Paul
    Grant, Steven
    [J]. CANCER RESEARCH, 2007, 67 (02) : 782 - 791
  • [7] Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
    De Nicola, Gina M.
    Karreth, Florian A.
    Humpton, Timothy J.
    Gopinathan, Aarthi
    Wei, Cong
    Frese, Kristopher
    Mangal, Dipti
    Yu, Kenneth H.
    Yeo, Charles J.
    Calhoun, Eric S.
    Scrimieri, Francesca
    Winter, Jordan M.
    Hruban, Ralph H.
    Iacobuzio-Donahue, Christine
    Kern, Scott E.
    Blair, Ian A.
    Tuveson, David A.
    [J]. NATURE, 2011, 475 (7354) : 106 - U128
  • [8] p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis
    Dolado, Ignacio
    Swat, Aneta
    Ajenjo, Nuria
    De Vita, Gabriella
    Cuadrado, Ana
    Nebreda, Angel R.
    [J]. CANCER CELL, 2007, 11 (02) : 191 - 205
  • [9] Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
    Donate, F.
    Juarez, J. C.
    Burnett, M. E.
    Manuia, M. M.
    Guan, X.
    Shaw, D. E.
    Smith, E. L. P.
    Timucin, C.
    Braunstein, M. J.
    Batuman, O. A.
    Mazar, A. P.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 776 - 783
  • [10] Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
    DuPage, Michel
    Dooley, Alison L.
    Jacks, Tyler
    [J]. NATURE PROTOCOLS, 2009, 4 (07) : 1064 - 1072